title: Statins: the case for higher, individualized starting doses.
abstract: If patients with hypercholesterolemia were started on higher doses of statins tailored to their lipid levels and risk, more of them would achieve their low-density lipoprotein cholesterol (LDL-C) goals, possibly leading to fewer cardiovascular events and deaths.
authors.affiliation: Lipid Metabolism and Atherosclerosis Clinic, Section of Atherosclerosis and Lipid Research, Baylor College of Medicine, Houston, TX, USA. jones@bcm.tmc.edu
authors.forename: Peter H
authors.initials: PH
authors.lastname: Jones
mesh_terms: D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors